Gene · 6876
Papers4,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pericytes promote metastasis by regulating tumor local vascular tone and hemodynamics. | Nat Commun | 2025 | 40753165 | PubTator, text mining | PubMed |
| Uncovering the molecular mechanisms of Qingdu Zengye Decoction in the treatment of nasopharyngeal carcinoma: an integrative investigation. | Front Pharmacol | 2025 | 40746726 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| Azithromycin and oesophageal motility in chronic respiratory disease: a feasibility study. | Ther Adv Respir Dis | 2025 | 40734318 | PubTator, text mining | PubMed |
| miR-10a-5p inhibits cardiac fibrosis by targeting the MRTF-A/TGF-β2 feedback loop. | Cell Signal | 2025 | 40639669 | PubTator, text mining | PubMed |
| GALNT4 controls aortic dissection by regulating vascular smooth muscle cell phenotype switch and dysfunction through the TGF-β/smad signaling. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40614980 | PubTator, text mining | PubMed |
| Deciphering the Regulatory Networks of the Migrasome-Associated Cell Subpopulation in Heterotopic Ossification via Multi-Omics Analysis. | FASEB J | 2025 | 40540299 | PubTator, text mining | PubMed |
| Disruption of LDL receptor trafficking in placentas from maternal supraphysiological hypercholesterolemia: A study of key endocytosis and recycling proteins. | Placenta | 2025 | 40517484 | PubTator, text mining | PubMed |
| Identification of adipose-proximal biomarkers in breast cancer using weighted gene co-expression network analysis. | Protoplasma | 2025 | 40498134 | PubTator, text mining | PubMed |
| Circular RNA hsa_circ_0008433 drives vascular smooth muscle cell modulation in intracranial aneurysm pathogenesis. | Adv Clin Exp Med | 2025 | 40474527 | PubTator, text mining | PubMed |
| The Mechanism of Matrilin-2 Inhibiting the Progression of In-Stent Restenosis for Lower Extremity Arteriosclerosis Obliterans via TGF-β/Smad Signaling Pathway. | Ann Vasc Surg | 2025 | 40441430 | PubTator, text mining | PubMed |
| MAP2K2 Knockdown Suppresses Phenotypic Transformation of Vascular Smooth Muscle Cells in Aortic Dissection by Inactivating the JAK/STAT Signaling Pathway. | FASEB J | 2025 | 40437968 | PubTator, text mining | PubMed |
| Serum-free endothelial cell culture medium for vascular smooth muscle cells sheet formation. | J Biol Eng | 2025 | 40437617 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Trabecular Meshwork Progenitor Cells. | Stem Cell Rev Rep | 2025 | 40423739 | PubTator, text mining | PubMed |
Proteome-driven transcriptomic dissection of EMT networks in bladder cancer based on the VIM and CDH2 protein macromolecules influence: From molecular-protein subtyping to therapeutic target prioritization. | Int J Biol Macromol | 2025 | 40419050 | PubTator, text mining | PubMed |
| Comprehensive analysis of the critical role of the epithelial mesenchymal transition subtype - TAGLN-positive fibroblasts in colorectal cancer progression and immunosuppression. | Cell Biosci | 2025 | 40413514 | PubTator, text mining | PubMed |
| Human endothelial colony forming cells (ECFCs) require endothelial protein C receptor (EPCR) for cell cycle progression and angiogenic activity. | Angiogenesis | 2025 | 40407837 | PubTator, text mining | PubMed |
| Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. | J Transl Med | 2025 | 40380267 | PubTator, text mining | PubMed |
| Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme. | Cell Biosci | 2025 | 40375334 | PubTator, text mining | PubMed |
| Novel carbazole attenuates vascular remodeling through STAT3/CIAPIN1 signaling in vascular smooth muscle cells. | Acta Pharm Sin B | 2025 | 40370537 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6876/papers?page=9